Bluebird Bio reported $0 in Trade Debtors for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Trade Debtors Change
Acceleron Pharma XLRN:US $ 27.94M 2.73M
Alexion Pharmaceuticals ALXN:US $ 1473M 63.7M
Alnylam Pharmaceuticals ALNY:US $ 646.59M 35.96M
Amgen AMGN:US $ 4479M 56M
Arrowhead Research ARWR:US $ 0.67M 0.28M
Avrobio Inc AVRO:US 2.33M 407K
Biogen BIIB:US $ 2110.2M 113.9M
Biomarin Pharmaceutical BMRN:US $ 424.42M 28.32M
Bluebird Bio BLUE:US $ 0M 0M
Dicerna Pharmaceuticals DRNA:US $ 5.01M 26.25M
Gilead Sciences GILD:US $ 4149M 224M
Immunogen IMGN:US $ 20.36M 0.68M
Intercept Pharmaceuticals ICPT:US $ 45.25M 2.66M
IONIS PHARMACEUT IONS:US $ 24M 0.61M
Mirati Therapeutics MRTX:US $ 67.12M 65.28M
Moderna Inc MRNA:US 2.07B 1.16B
Nektar Therapeutics NKTR:US $ 28.87M 0.28M
Novartis NOVN:VX 8.65B 173M
Ptc Therapeutics PTCT:US $ 78.8M 15.32M
Regeneron Pharmaceuticals REGN:US $ 6998.6M 2825.6M
Sangamo Biosciences SGMO:US $ 7.69M 0.03M
Sarepta Therapeutics SRPT:US $ 148.26M 11.9M
Seattle Genetics SGEN:US $ 379.74M 43.91M
Ultragenyx Pharmaceutical RARE:US $ 24.72M 0.31M
Vertex Pharmaceuticals VRTX:US $ 929.14M 48.41M
YTE INCY:US $ 438.17M 40.81M